| Name | Title | Contact Details |
|---|
Robins Landing Senior Living is an assisted living facility in New Berlin that provides compassionate care to residents. They strive to create a warm and welcoming home-like atmosphere that is safe, secure, and uplifting.
BLOSSOM SOUTH is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lifemasters Supported Selfcare is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Lifemasters Supported Selfcare is based in South San Francisco, CA. You can find more information on Lifemasters Supported Selfcare at www.lifemasters.net
Presbyterian Homes & Services (PHS), based in St. Paul, Minnesota, is a non-profit, faith-based organization providing a broad array of high quality housing choices, and care and service options for older adults. Over 7,100 employees serve more than 26,000 older adults through 59 PHS-affiliated senior living communities in Minnesota, Iowa and Wisconsin, and through Optage® home and community services. PHS is also co-owner of Genevive, the largest geriatric primary care practice in Minnesota, providing comprehensive care for over 15,000 older adults. Established in 1955, PHS has earned the reputation as an innovative leader dedicated to promoting independence, purposeful living, and overall well-being for those they serve. Today, PHS is one of the largest nonprofit providers of senior housing and services in the nation. The mission of Presbyterian Homes & Services is to honor God by enriching the lives and touching the hearts of older adults. By living our values in our daily work, we create smiles in the eyes of the people we serve. These value statements form the word “CROSS” and are central to how we do what we do: Christian Ministry - Reflect the love of God Ready and Engaged People - Create ownership and utilize strengths Operational Integrity - Do what we said we would do Service Excellence - Create an exceptional customer experience Stewardship - Optimize resources and expand ministry
Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.